Credit Suisse analyst Matt Miksic maintains Align Tech (NASDAQ:ALGN) with a Outperform and lowers the price target from $782 to $722.
HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Lowers Price Target to $61
HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and lowers the price target from $69 to $61.